N/A
N=32
Overnight Pant Study for Children With Nocturnal Enuresis
Nocturnal Enuresis
Bottom Line
View on ClinicalTrials.gov: NCT05178641 ↗Enrolled (actual)
32
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcome: Primary: Number, Frequency and Severity of Product Related Adverse Events — 47; 63; 110; 5 Number of product related Adverse Events
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Ninjamas Pyjama Pants (Device); Participant's Overnight Current Standard of Care (Other)
- Age
- Pediatric · 4+ yrs
- Sex
- All
- Sponsor
- Procter and Gamble
- Primary completion
- Feb 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number, Frequency and Severity of Product Related Adverse Events |
47; 63; 110; 5; 4; 9 | — |
| SECONDARY Parent Assessed Product Performance in Terms of Urine Leaking |
2; 0; 2; 8; 3; 11 | — |
Summary
This study will evaluate the in-use tolerance of an absorbent disposable underwear pant developed for children with nocturnal enuresis by assessing adverse events. In addition product performance will be assessed by the parent at home via a daily diary.
Eligibility Criteria
Inclusion Criteria
Participants are eligible for enrollment if the parent/legal guardian responds positively ("Yes") to the following questions:
- Have you read, understood and signed the Informed Consent document?
- Is your child generally healthy?
- Is your child 4-7 years of age?
- Does your child weigh approximately 37-63 pounds and fit into the test pant?
- Thinking of the past 3 months, does your child wet the bed at night at least once per week?
- Is your child currently using overnight pants or diapers?
- Is your child willing to use their usual and/or supplied overnight pant products every night for the duration of the study?
- Are you and your child willing to refrain from using wet wipes in the pant area for the duration of the clinical trial?
- Are you willing to refrain from enrolling your child in other clinical or consumer studies for the duration of this clinical trial?
- Are you and your child willing to refrain from using lotions, creams, ointments, oils, moisturizing bubble baths, powders, sunscreen and/or skin preparations in the child's pant area and on thighs for the duration of this clinical trial, unless required for medical reasons?
- Are you and your child willing and able to comply with all study instructions?
- Are you able to fill in the required questionnaires in English?
Exclusion Criteria
Participants are ineligible for enrollment if the parent/legal guardian responds positively ("Yes") to any of the following questions:
- Does your child have any acute or chronic skin conditions (excluding skin rash) in or around the pant area?
- Does your child currently have (or have a history of) any significant illness or chronic medical condition?
- Is your child currently using any medications?
- Does your child currently wear absorbent products during the day?
- Does your child suffer from any other lower urinary tract symptoms (e.g., increased frequency, daytime incontinence, urgency, genital, or lower urinary tract pain) or a history of bladder dysfunction?
Data sourced from ClinicalTrials.gov (NCT05178641). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.